Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDMO
CRO
WuXi AppTec posts sales decline but picks up new business in Q3
With the specter of the BIOSECURE Act clouding its future, China’s WuXi AppTec sustained its fourth straight quarter with a revenue decline.
Kevin Dunleavy
Oct 29, 2024 8:25am
Biopharma Q2 VC hit highest level since ’22, while M&A slowed
Aug 23, 2024 4:00am
Charles River Labs partners with Wheeler Bio for CMC platform
Feb 26, 2024 3:15pm
QHP buys cell and gene therapy specialist Applied StemCell
Oct 9, 2023 10:20am
GlucoModicum taps Phillips-Medisize to develop needle-free CGM
Oct 4, 2023 10:55am
NightHawk dives into CDMO, leaving R&D staffers in the lurch
Sep 20, 2023 10:33am
